Literature DB >> 25008396

LRRK2 parkinsonism in Tunisia and Norway: a comparative analysis of disease penetrance.

Faycel Hentati1, Joanne Trinh1, Christina Thompson1, Ekaterina Nosova1, Matthew J Farrer2, Jan O Aasly1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25008396      PMCID： PMC4142000          DOI： 10.1212/WNL.0000000000000675

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

1.  LRRK2 Gly2019Ser penetrance in Arab-Berber patients from Tunisia: a case-control genetic study.

Authors:  Mary M Hulihan; Lianna Ishihara-Paul; Jennifer Kachergus; Liling Warren; Rim Amouri; Ramu Elango; Rab K Prinjha; Ruchi Upmanyu; Mounir Kefi; Mourad Zouari; Samia Ben Sassi; Samia Ben Yahmed; Ghada El Euch-Fayeche; Paul M Matthews; Lefkos T Middleton; Rachel A Gibson; Fayçal Hentati; Matthew J Farrer
Journal:  Lancet Neurol       Date:  2008-06-06       Impact factor: 44.182

2.  Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease.

Authors:  Stefano Goldwurm; Sara Tunesi; Silvana Tesei; Michela Zini; Francesca Sironi; Paola Primignani; Corrado Magnani; Gianni Pezzoli
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

3.  Genealogical studies in LRRK2-associated Parkinson's disease in central Norway.

Authors:  Krisztina K Johansen; Kåre Hasselberg; Linda R White; Matthew J Farrer; Jan O Aasly
Journal:  Parkinsonism Relat Disord       Date:  2010-07-10       Impact factor: 4.891

4.  Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populations.

Authors:  Jennifer Kachergus; Ignacio F Mata; Mary Hulihan; Julie P Taylor; Sarah Lincoln; Jan Aasly; J Mark Gibson; Owen A Ross; Timothy Lynch; Joseph Wiley; Haydeh Payami; John Nutt; Demetrius M Maraganore; Krzysztof Czyzewski; Maria Styczynska; Zbigniew K Wszolek; Matthew J Farrer; Mathias Toft
Journal:  Am J Hum Genet       Date:  2005-02-22       Impact factor: 11.025

5.  Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism.

Authors:  Joanne Trinh; Rim Amouri; John E Duda; James F Morley; Matthew Read; Alan Donald; Carles Vilariño-Güell; Christina Thompson; Chelsea Szu Tu; Emil K Gustavsson; Samia Ben Sassi; Emna Hentati; Mourad Zouari; Emna Farhat; Fatma Nabli; Faycel Hentati; Matthew J Farrer
Journal:  Neurobiol Aging       Date:  2013-11-22       Impact factor: 4.673

Review 6.  Advances in the genetics of Parkinson disease.

Authors:  Joanne Trinh; Matt Farrer
Journal:  Nat Rev Neurol       Date:  2013-07-16       Impact factor: 42.937

7.  What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study.

Authors:  A J Hughes; Y Ben-Shlomo; S E Daniel; A J Lees
Journal:  Neurology       Date:  1992-06       Impact factor: 9.910
  7 in total
  18 in total

Review 1.  LRRK2 in Parkinson disease: challenges of clinical trials.

Authors:  Eduardo Tolosa; Miquel Vila; Christine Klein; Olivier Rascol
Journal:  Nat Rev Neurol       Date:  2020-01-24       Impact factor: 42.937

2.  Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 Consortium.

Authors:  Karen Marder; Yuanjia Wang; Roy N Alcalay; Helen Mejia-Santana; Ming-Xin Tang; Annie Lee; Deborah Raymond; Anat Mirelman; Rachel Saunders-Pullman; Lorraine Clark; Laurie Ozelius; Avi Orr-Urtreger; Nir Giladi; Susan Bressman
Journal:  Neurology       Date:  2015-06-10       Impact factor: 9.910

Review 3.  Biomarkers of Parkinson's disease: 20 years later.

Authors:  Rezzak Yilmaz; Franziska Hopfner; Thilo van Eimeren; Daniela Berg
Journal:  J Neural Transm (Vienna)       Date:  2019-04-04       Impact factor: 3.575

4.  The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3.

Authors:  Shi-Rui Gan; Karla P Figueroa; Hao-Ling Xu; Susan Perlman; George Wilmot; Christopher M Gomez; Jeremy Schmahmann; Henry Paulson; Vikram G Shakkottai; Sarah H Ying; Theresa Zesiewicz; Khalaf Bushara; Michael D Geschwind; Guangbin Xia; S H Subramony; Liana Rosenthal; Tetsuo Ashizawa; Stefan M Pulst; Ning Wang; Sheng-Han Kuo
Journal:  Parkinsonism Relat Disord       Date:  2020-02-17       Impact factor: 4.891

5.  Efficient Estimation of Nonparametric Genetic Risk Function with Censored Data.

Authors:  Yuanjia Wang; Baosheng Liang; Xingwei Tong; Karen Marder; Susan Bressman; Avi Orr-Urtreger; Nir Giladi; Donglin Zeng
Journal:  Biometrika       Date:  2015-09-01       Impact factor: 2.445

6.  Novel recruitment strategy to enrich for LRRK2 mutation carriers.

Authors:  Tatiana Foroud; Danielle Smith; Jacqueline Jackson; Jennifer Verbrugge; Cheryl Halter; Leah Wetherill; Katherine Sims; Winnie Xin; Vanessa Arnedo; Shirley Lasch; Kenneth Marek
Journal:  Mol Genet Genomic Med       Date:  2015-05-06       Impact factor: 2.183

Review 7.  Genetics and genomics of Parkinson's disease.

Authors:  Michelle K Lin; Matthew J Farrer
Journal:  Genome Med       Date:  2014-06-30       Impact factor: 11.117

8.  Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.

Authors:  Bjørg Johanne Warø; Jan O Aasly
Journal:  Brain Behav       Date:  2017-12-07       Impact factor: 2.708

9.  α-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease.

Authors:  Alicia Garrido; Graham Fairfoul; Eduardo S Tolosa; Maria José Martí; Alison Green
Journal:  Ann Clin Transl Neurol       Date:  2019-05-09       Impact factor: 4.511

10.  Clinical characterization of patients with leucine-rich repeat kinase 2 genetic variants in Japan.

Authors:  Yuanzhe Li; Aya Ikeda; Hiroyo Yoshino; Genko Oyama; Mitsuhiro Kitani; Kensuke Daida; Arisa Hayashida; Kotaro Ogaki; Kousuke Yoshida; Takashi Kimura; Yoshiaki Nakayama; Hidefumi Ito; Naoto Sugeno; Masashi Aoki; Hiroaki Miyajima; Katsuo Kimura; Naohisa Ueda; Masao Watanabe; Takao Urabe; Masashi Takanashi; Manabu Funayama; Kenya Nishioka; Nobutaka Hattori
Journal:  J Hum Genet       Date:  2020-05-13       Impact factor: 3.172
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.